Acute resolving viral infections are often associated with a strong and multi-specific T-cell response, whereas in persistent viral infections T-cell responses are often impaired. It has been suggested that the resuscitation of the antiviral T-cell response could be a powerful tool to target persisting viruses. Several immunoregulatory pathways, such as IL-10 and TGF-β, have been shown to be involved in the induction of T-cell exhaustion and viral persistence. In this study, we sought to investigate whether TGF-β signaling is also relevant in the maintenance of T-cell exhaustion after viral persistence has been established, and whether blockade of TGF-β signaling could improve control of viral replication in a mouse model of persistent virus infection. Using the LCMV clone 13 model, we analyzed the frequency, function, and phenotype of virus-specific CD4 and CD8 T cells following therapeutic TGF-β signaling blockade. We show that in vivo blockade of the TGF-β receptor failed to substantially enhance the antiviral T-cell response, and was insufficient to mediate a therapeutically-relevant reduction of viral titers in different tissues. Thus, although TGF-β signaling has the ability to hamper antiviral immunity, its pharmacological blockade may not be sufficient to tackle persistent viruses.
Get full access to this article
View all access options for this article.
References
1.
ThompsonMA, AbergJA, CahnPet al.Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA, 2010; 304:321–333.
2.
GhanyMG, StraderDB, ThomasDL, SeeffLB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology, 2009; 49:1335–1374.
3.
TinocoR, AlcaldeV, YangYet al.Cell-intrinsic transforming growth factor-beta signaling mediates virus-specific CD8+ T cell deletion and viral persistence in vivo. Immunity, 2009; 31:145–157.
4.
EjrnaesM, FilippiCM, MartinicMMet al.Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med, 2006; 203:2461–2472.
5.
BrooksDG, TrifiloMJ, EdelmannKHet al.Interleukin-10 determines viral clearance or persistence in vivo. Nat Med, 2006; 12:1301–1309.
6.
BrooksDG, WalshKB, ElsaesserH, OldstoneMB. IL-10 directly suppresses CD4 but not CD8 T cell effector and memory responses following acute viral infection. Proc Natl Acad Sci USA, 2010; 107:3018–3023.
7.
BrooksDG, HaSJ, ElsaesserHet al.IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection. Proc Natl Acad Sci USA, 2008; 105:20428–20433.
8.
BrooksDG, LeeAM, ElsaesserHet al.IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection. J Exp Med, 2008; 205:533–541.
9.
OldstoneMB. A suspenseful game of ‘hide and seek’ between virus and host. Nat Immunol, 2007; 8:325–327.
10.
BowenDG, WalkerCM. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature, 2005; 436:946–952.
11.
BarberDL, WherryEJ, MasopustDet al.Restoring function in exhausted CD8 T cells during chronic viral infection. Nature, 2006; 439:682–687.
12.
UrbaniS, AmadeiB, TolaDet al.PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J Virol, 2006; 80:11398–11403.
13.
DayCL, KaufmannDE, KiepielaPet al.PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature, 2006; 443:350–354.
14.
BengschB, SeigelB, RuhlMet al.Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation. PLoS Pathog, 2010; 6:e1000947.
15.
InmanGJ, NicolasFJ, CallahanJFet al.SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol, 2002; 62:65–74.
16.
WaghabiMC, de SouzaEM, de OliveiraGMet al.Pharmacological inhibition of transforming growth factor beta signaling decreases infection and prevents heart damage in acute Chagas' disease. Antimicrob Agents Chemother, 2009; 53:4694–4701.
17.
GraingerJR, SmithKA, HewitsonJPet al.Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-beta pathway. J Exp Med, 2010; 207:2331–2341.
18.
MikamiF, LimJH, IshinagaHet al.The transforming growth factor-beta-Smad3/4 signaling pathway acts as a positive regulator for TLR2 induction by bacteria via a dual mechanism involving functional cooperation with NF-kappaB and MAPK phosphatase 1-dependent negative cross-talk with p38 MAPK. J Biol Chem, 2006; 281:22397–22408.
19.
WangC, McPhersonAJ, JonesRBet al.Loss of the signaling adaptor TRAF1 causes CD8+ T cell dysregulation during human and murine chronic infection. J. Exp Med, 2012; 209:77–91.
20.
RigbyMR, TrexlerAM, PearsonTC, LarsenCP. CD28/CD154 blockade prevents autoimmune diabetes by inducing nondeletional tolerance after effector T-cell inhibition and regulatory T-cell expansion. Diabetes, 2008; 57:2672–2683.
21.
FahlenL, ReadS, GorelikLet al.T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J Exp Med, 2005; 201:737–746.
22.
Braley-MullenH, ChenK, WeiY, YuS. Role of TGFbeta in development of spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J Immunol, 2001; 167:7111–7118.
23.
McCauslandMM, CrottyS. Quantitative PCR technique for detecting lymphocytic choriomeningitis virus in vivo. J Virol Methods, 2008; 147:167–176.
24.
LeeKJ, PerezM, PinschewerDD, de la TorreJC. Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles. J Virol, 2002; 76:6393–6397.
25.
AhmedR, SalmiA, ButlerLDet al.Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J Exp Med, 1984; 160:521–540.
26.
van der MostRG, Murali-KrishnaK, LanierJGet al.Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation. Virology, 2003; 315:93–102.
27.
WherryEJ, BlattmanJN, Murali-KrishnaKet al.Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol, 2003; 77:4911–4927.
28.
MuellerSN, AhmedR. High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proc Natl Acad Sci USA, 2009; 106:8623–8628.
29.
WherryEJ, HaSJ, KaechSMet al.Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity, 2007; 27:670–684.
30.
JoshiNS, CuiW, ChandeleAet al.Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-beta transcription factor. Immunity, 2007; 27:281–295.
31.
ShinH, BlackburnSD, IntlekoferAMet al.A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection. Immunity, 2009; 31:309–320.
32.
PellegriniM, CalzasciaT, ToeJGet al.IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology. Cell, 2011; 144:601–613.
33.
JinHT, AndersonAC, TanWGet al.Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci USA, 2010; 107:14733–14738.
